Douglas Elliman Inc. announced its financial results for the fourth quarter and full year ended December 31, 2024, on March 10, 2025. Fourth quarter revenues increased to $243.3 million, up from $214.1 million in Q4 2023, representing a 13.6% year-over-year growth.
The company significantly narrowed its operating loss in Q4 2024 to $16.3 million, an improvement from $23.6 million in the prior-year quarter. Net loss also improved to $6.0 million, or $0.07 per diluted common share, compared to $14.8 million, or $0.18 per diluted common share, in Q4 2023.
Adjusted EBITDA loss for Q4 2024 improved to $5.4 million from $16.7 million in Q4 2023, and Adjusted Net Income reached $2.4 million, or $0.03 per diluted share, a substantial improvement from a loss of $13.7 million in Q4 2023. Gross Transaction Value for Q4 2024 increased by 11.4% to $8.8 billion.
For the full year 2024, revenues were $995.6 million, a 4.2% increase from $955.6 million in 2023. The full-year Adjusted EBITDA loss improved to $17.8 million from $39.9 million in 2023, and Adjusted Net loss narrowed to $24.0 million, or $0.29 per diluted share, from $40.1 million in 2023.
Management noted strong momentum carrying into 2025, with cash receipts in January and February up approximately 30% compared to the same period last year. The company maintained a strong balance sheet with $135.7 million in cash and cash equivalents at December 31, 2024.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.